Works matching IS 18387640 AND DT 2022 AND VI 12 AND IP 4


Results: 29
    1
    2
    3

    The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer.

    Published in:
    Theranostics, 2022, v. 12, n. 4, p. 1904, doi. 10.7150/thno.66814
    By:
    • Qi-Yue Chen;
    • Xiao-Bo Huang;
    • Ya-Jun Zhao;
    • Hua-Gen Wang;
    • Jia-Bin Wang;
    • Li-Chao Liu;
    • Ling-Qian Wang;
    • Qing Zhong;
    • Jian-Wei Xie;
    • Jian-Xian Lin;
    • Jun Lu;
    • Long-Long Cao;
    • Mi Lin;
    • Ru-Hong Tu;
    • Chao-Hui Zheng;
    • Ping Li;
    • Chang-Ming Huang
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    14
    15
    16
    17

    Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.

    Published in:
    Theranostics, 2022, v. 12, n. 4, p. 1715, doi. 10.7150/thno.54453
    By:
    • Alaterre, Elina;
    • Ovejero, Sara;
    • Herviou, Laurie;
    • de Boussac, Hugues;
    • Papadopoulos, Giorgio;
    • Kulis, Marta;
    • Boireau, Stéphanie;
    • Robert, Nicolas;
    • Requirand, Guilhem;
    • Bruyer, Angélique;
    • Cartron, Guillaume;
    • Vincent, Laure;
    • Martinez, Anne Marie;
    • Martin-Subero, José Ignacio;
    • Cavalli, Giacomo;
    • Moreaux, Jerome
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29